Includes symposiums listed below:i.Intergration of Vascular biology into understanding coronary artery diseases, June 19,2003. ii.A symposi um: International update on The Role of Aldosterone and Aldosterone Ant agonism in Cardiovascular medicine, June 19, 1990. iii.A symposium: The significance of High-density lipoprotein cholesterol in the prevention of coronary disease,Sept. 4, 1990.iv.A symposium:The Triggering and ci vcadian variations of onset of acute cardiovascular disease, Nov.6,1990 .v. Asymposium: atherosclerosis and vascular protection, Dec., 1990. vi .Pharmacologic and Therapeudic aspects of Urapidil,Aug. 15,1989. vii.a symposium:New developments in the treatment of hypercholesterolemia- pr obucol, June 27, 1986.viii.A symposium: Clinical applications of non se lective beta blockers, April 25, 1986.ix.A symposium Guanfactive- a new choice in centrally acting antihypertensive agents,Reprinted from Mar ch 28,1986. x.A symposium: Lipids and hypertension in elderly, Reprinte d from Feb 12 1986. xi. Abstracts; 26th annual scientific session, Amer ican College of Cardiology, March 7-10, Las Vegas Nevada.

Suppliment to Vol.91, No.12, 2003. A syposium on:Intergration of Vas cular biology into understanding coronary artery diseases.

The American College of Cardiology